Validation of the 12-gene predictive signature for Adjuvant Chemotherapy Response in Lung Cancer

PURPOSE: Response to adjuvant chemotherapy (ACT) after tumor resection varies widely among non-small cell lung cancer (NSCLC) patients; therefore, it is of clinical importance to prospectively predict who will benefit from ACT before starting the treatment. The goal of this study is to validate a 12...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Xie, Yang, Lu, Wei, Wang, Shidan, Tang, Ximing, Tang, Hao, Zhou, Yunyun, Moran, Cesar, Behrens, Carmen, Roth, Jack, Zhou, Qinghua, Johnson, David, Swisher, Stephen, Heymach, John, Papadimitrakopoulou, Vassiliki, Xiao, Guanghua, Minna, John, Wistuba, Ignacio
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274213/
https://ncbi.nlm.nih.gov/pubmed/30287547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-2543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados